Search

everythinglearnresearchcommunity

for

Search:↓

L-(+)-Tartaric Acid may help increase certain hair growth genes without harming cells.

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.

AL136131.3 slows hair growth by affecting energy processes in hair loss.

MOTILIPERM may help treat male infertility by reducing stress in cells.

Serotonin helps wounds heal faster.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

The new assay can help develop products for hair re-growth.

Loliolide can boost hair growth by activating specific cell pathways.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

Melatonin could be an effective treatment for Alzheimer's Disease and rosacea.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

RORA boosts autophagy in hair follicle stem cells, potentially aiding hair growth.

Anastrozole and cyproterone acetate treatment can help increase adult height in boys with testotoxicosis.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

The study suggests that changes in immune system receptors and their interaction with a cell component may be important in the development of a type of hair loss condition.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

The MDR1 C3435T polymorphism does not significantly affect methotrexate response in rheumatoid arthritis patients.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Hormonal therapies effectively treat acne and improve quality of life.